Home » Stocks » PTIX

Protagenic Therapeutics, Inc. (PTIX)

Stock Price: $2.94 USD -0.43 (-12.76%)
Updated Jun 18, 2021 4:00 PM EDT - Market closed
After-hours: $2.95 +0.01 (0.34%) Jun 18, 7:59 PM
Market Cap 43.05M
Revenue (ttm) n/a
Net Income (ttm) -3.34M
Shares Out 14.64M
EPS (ttm) -0.31
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day June 18
Last Price $2.94
Previous Close $3.37
Change ($) -0.43
Change (%) -12.76%
Day's Open 3.41
Day's Range 2.94 - 3.73
Day's Volume 6,507,411
52-Week Range 1.84 - 4.89

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

Looking for biotech penny stocks for your June watchlist? Here's 4 to watch The post Best Biotech Penny Stocks in June 2021?

Other stocks mentioned: PIRS, SESN, TTOO
3 weeks ago - PennyStocks

These biotech penny stocks pushed up big today; but are they worth it? The post 4 Biotech Penny Stocks That You Need to Know About appeared first on Penny Stocks to Buy, Picks, News and Information | Pe...

Other stocks mentioned: IBIO, OBLN, PRPO
1 month ago - PennyStocks

Joins us as we take a look at the most volatile stocks for Monday as many shares see their prices fluctuate during the day. The post Market Update: The 10 Most Volatile Stocks Today appeared first on In...

Other stocks mentioned: APOP, CKX, CUE, ELTK, LEDS, OBLN, PRPO ...
1 month ago - InvestorPlace

New York, April 29, 2021 (GLOBE NEWSWIRE) -- Protagenic Therapeutics, Inc. (NASDAQ:PTIX) ("PTIX" or "Company") today announced the closing of an underwritten public offering of 3,180,000 units at a publ...

1 month ago - GlobeNewsWire

New York, April 26, 2021 (GLOBE NEWSWIRE) -- Protagenic Therapeutics, Inc. (NASDAQ:PTIX) ("PTIX" or "Company") today announced the pricing of an underwritten public offering of 3,180,000 units at a publ...

1 month ago - GlobeNewsWire

About PTIX

Protagenic Therapeutics, Inc., a pre-clinical biopharmaceutical company, engages in the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. Its lead compound, PT00114 is a synthetic form of teneurin carboxy-terminal associated peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. The company was founded in 2016 and is based in New York, New York.

Industry
Biotechnology
IPO Date
Jan 5, 2016
Stock Exchange
NASDAQ
Ticker Symbol
PTIX
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecasts

The average 12-month stock price forecast for PTIX is 4.50, which is an increase of 53.06% from the latest price.

Price Target
$4.50
(53.06% upside)